CoreDISTp: Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility Study

Sponsor
Nordlandssykehuset HF (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05057338
Collaborator
Nord University (Other), Hasselt University (Other), Helse Nord (Industry)
30
2
2
12.1
15
1.2

Study Details

Study Description

Brief Summary

Multiple Sclerosis (MS) is a chronic disease affecting young adults. Impaired balance, walking, reduced physical activity and participation in employment are common, however, less integrated in the health care. The researchers have developed a multidisciplinary intervention and pathway delivered across health care levels targeting the promotion of balance, walking, physical activity and participation in employment. The research team will perform a pilot feasibility Randomized Controlled Trial (RCT) and interviews to investigate the feasibility of the new intervention compared to a standard care for individuals with lower levels of disability.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CoreDISTparticipation
  • Behavioral: Standard care
N/A

Detailed Description

The study addresses core elements in the health services for individuals with MS, constituting approximately 11000 in Norway. The two-armed pilot feasibility-RCT will be performed across the MS-outpatient (MS-OP) clinic, Nordland Hospital Trust, Bodø (NLSH), and in two surrounding municipalities, including 30 employed participants who will be followed for 10-weeks. The new intervention and pathway, CoreDISTparticipation, builds on GroupCoreDIST, which is previously found effective short and long term compared to standard care. CoreDISTparticipation consists of three phases: a) at the MS-OP clinic, in addition to the regular consultations, the patient will have a structured digital conversation with the MS-nurse addressing work related issues and a session with a physiotherapist exploring possibilities for change in balance and walking; b) in the municipality, a physiotherapist will continue exploration of improvements, followed by four weeks of GroupCoreDIST for 60 minutes, 2 times per week supplemented with home exercise programs focusing on balance, walking and physical activity. The participants will have access to exercise programs on videos through an open website at Nord University to digitally support home training.

To promote participation in employment, a structured digital meeting between each patient, the MS-nurse, the patient's employer, and the physiotherapist (who leads the group trainings) will take place in phase b; followed by phase c) which include four weeks of outdoor group based exercises and physical activity led by a physiotherapist, for 60 minutes, 2 times per week supplemented with the same home exercise programs as in phase b.

Evaluation of employment and physical activity will be conducted using an evaluation form.

The control group will receive usual consultations at the MS-OP clinic, as well as a session with a physiotherapist at the MS-OP clinic, exploring possibilities for change in balance and walking. In the municipality the control group will follow standard care (their usual follow-up).

The research team will examine feasibility, preliminary between-group differences regarding balance, walking, physical activity level, health related quality of life and barriers in employment, as well as the users' experiences with participation in the CoreDISTparticipation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
RCT with two arms: intervention group and control group.RCT with two arms: intervention group and control group.
Masking:
Single (Outcomes Assessor)
Masking Description:
Assessor is masked for group allocation
Primary Purpose:
Treatment
Official Title:
Innovative Follow-up Across Health Care Levels to Optimize Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility Study
Actual Study Start Date :
Aug 27, 2021
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Aug 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: CoreDISTparticipation

a) at the MS-OP clinic, in addition to the regular consultations, the patient will have a structured digital conversation with the MS-nurse addressing work related issues and a session with a physiotherapist exploring possibilities for change in balance and walking; b) in the municipality, a physiotherapist will continue exploration of improvements, followed by four weeks of GroupCoreDIST focusing on balance, walking and physical activity and conducted in groups of 3-5 individuals with MS and led by a physiotherapist. To promote participation in employment, a structured digital meeting between each patient, the MS-nurse, the patient's employer, and the physiotherapist will take place; followed by c) four weeks of outdoor group based exercises and physical activity led by a physiotherapist, complemented with an evaluation form regarding employment and physical activity.

Behavioral: CoreDISTparticipation
CoreDISTparticipation is a thorough intervention that contains coordination of services (physiotherapy, MS-nursing and work adaptations) between the MS-OP clinic and the municipality aiming to improve function, physical activity and employment in individuals with MS.

Active Comparator: Standard care

The control group will receive the usual consultations at the MS-OP clinic including exploration of possibilities for change in balance and walking together with physiotherapist at the MS-OP clinic. The control group will furthermore follow standard care (their usual follow-up) in the municipality.

Behavioral: Standard care
The standard care group will follow regular consultations at the MS-outpatient clinic including a session with the physiotherapist. Furthermore, this group will follow usual care in the municipality which might include other forms of physiotherapy or physical activity. These will be registered.

Outcome Measures

Primary Outcome Measures

  1. MS Work Difficulties Questionnaire-23 [Baseline]

    How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0). (Recently translated to Norwegian).

  2. Six-Minutes Walk Test [Baseline]

    Walking distance within six minutes

  3. MS Work Difficulties Questionnaire-23 [5 weeks post-test]

    How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0). (Recently translated to Norwegian).

  4. Six-Minutes Walk Test [5 weeks post-test]

    Walking distance within six minutes

  5. MS Work Difficulties Questionnaire-23 [10 week post-test]

    How frequently individuals with MS perceive psychological/cognitive (11 items)-, physical (8 items)- and external barriers (4 items) related to their current or most recent job, and is scored by a five point scale (best score 0). (Recently translated to Norwegian).

  6. Six-Minutes Walk Test [10 week post-test]

    Walking distance within six minutes

Secondary Outcome Measures

  1. Trunk Impairment Scale Norwegian Version [Baseline]

    Dynamic sitting balance, 6 items, top score 16.

  2. Mini Balance Evaluation Systems Test [Baseline]

    Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28

  3. Force Platform [Baseline]

    The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance.

  4. Activity monitors outcome 1 [Baseline]

    The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days

  5. Activity monitors outcome 2 [Baseline]

    The monitors measure number of steps within 7 days

  6. European Quality of Life 5-Dimension-3 Level [Baseline]

    Self-perceived health related quality of life regarding five domains, each with three items, and a Visual Analog Scale (0-100) recording perceived health.

  7. Multiple Sclerosis Walking Scale-12 [Baseline]

    Limitations in walking due to MS on 12 items with a scale 1-5, best score 12

  8. Multiple Sclerosis Impact Scale-29 [baseline]

    Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29)

  9. Weight [baseline]

    Self reported weight by kilogram

  10. Height [baseline]

    Self reported height by centimetre

  11. age [baseline]

    Self reported age by years

  12. Social status [baseline]

    Self reported social status; married, cohabitant, living alone

  13. Type of multiple sclerosis [baseline]

    Self reported main types: relapsing remitting, primary progressive, secondary progressive

  14. Year of diagnosis multiple sclerosis [baseline]

    Self reported by year

  15. Medications [baseline]

    Self reported by type of medications

  16. Expanded disability status scale [baseline]

    Self reported or from journal functional status at last yearly control by a neurologist

  17. Occupation [baseline]

    Self reported

  18. Percentage of work [baseline]

    Self reported percentage of work the previous month

  19. Length of education [baseline]

    Self reported choices: elementary school; high school; bachelor; masters degree; Doctor of philosophy degree

  20. Trunk Impairment Scale Norwegian Version [5 weeks post-test]

    Dynamic sitting balance, 6 items, top score 16.

  21. Mini Balance Evaluation Systems Test [5 weeks post-test]

    Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28

  22. Force Platform [5 weeks post-test]

    The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance.

  23. Activity monitors outcome 1 [5 weeks post-test]

    The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days

  24. Activity monitors outcome 2 [5 weeks post-test]

    The monitors measure number of steps within 7 days

  25. European Quality of Life 5-Dimension-3 Level [5 weeks post-test]

    Self-perceived health related quality of life regarding

  26. Multiple Sclerosis Walking Scale-12 [5 weeks post-test]

    Limitations in walking due to MS on 12 items with a scale 1-5, best score 12

  27. Multiple Sclerosis Impact Scale-29 [5 weeks post-test]

    Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29)

  28. Percentage of work [5 weeks post-test]

    Self reported percentage of work

  29. Trunk Impairment Scale Norwegian Version [10 weeks post-test]

    Dynamic sitting balance, 6 items, top score 16.

  30. Mini Balance Evaluation Systems Test [10 weeks post-test]

    Pro-and reactive balance, dual task and involving sit to stand, standing and walking, 14 items on a 3 point with a top score of 28

  31. Force Platform [10 weeks post-test]

    The force platform measures control in standing: symmetry/asymmetry of weight bearing with eyes open/closed, postural sway of center of pressure, and weight transfer which all together will present an outcome for standing balance.

  32. Activity monitors outcome 1 [10 weeks post-test]

    The monitors measure Physical activity levels (inactive, light, moderate, vigorous) within 7 days

  33. Activity monitors outcome 2 [10 weeks post-test]

    The monitors measure number of steps within 7 days

  34. European Quality of Life 5-Dimension-3 Level [10 weeks post-test]

    Self-perceived health related quality of life regarding

  35. Multiple Sclerosis Walking Scale-12 [10 weeks post-test]

    Limitations in walking due to MS on 12 items with a scale 1-5, best score 12

  36. Multiple Sclerosis Impact Scale-29 [10 weeks post-test]

    Self-perceived physical (13 items) and psychological (9 items) impact due to MS on health related quality of life recorded by a five point scale (best score 29)

  37. Percentage of work [10 weeks post-test]

    Self reported percentage of work

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 68 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with MS (Mc Donald's criteria), Expanded Disability Status Scale ≤3.5 (no disability-fully ambulatory with moderate disability), ≥18 years, being employed. By these criteria the study will include individuals most accessible for the intervention and who have the best prospects to maintain/improve balance, walking, physical activity and participation in employment.
Exclusion Criteria:
  • Retired, pregnancy at enrolment, exacerbation within two weeks prior to enrolment and other serious conditions compromising balance, walking or work capacity.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bodø Municipality Bodø Norway
2 Physiotherapy department, Nordlandssykehuset HF Bodø Norway

Sponsors and Collaborators

  • Nordlandssykehuset HF
  • Nord University
  • Hasselt University
  • Helse Nord

Investigators

  • Study Director: Petter Oien, PhD, Nordlandssykehuset HF

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nordlandssykehuset HF
ClinicalTrials.gov Identifier:
NCT05057338
Other Study ID Numbers:
  • CoreDISTparticipation
First Posted:
Sep 27, 2021
Last Update Posted:
Sep 27, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nordlandssykehuset HF
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 27, 2021